• New record number of daily COVID-19 cases
US indices erased earlier gains and are trading lower as investors remain concerned about the progress of the stimulus bill negotiations. While House Speaker Nancy Pelosi remains optimistic that a stimulus can be reached, she also admitted that it may take a while for legislation to be written and signed. Meanwhile President Trump said today, that he does not want the aid deal to bail out Democratic states, according to Reuters. Mnuchin also reportedly said there are still “significant differences” between the two sides. On the corporate front, Intel's stock plunged over 10% on mixed quarterly results. On the data front flash Markit PMI data pointed out that US economy is slowly recovering. Investors also welcomed the fact that Gilead Sciences’ antiviral drug remdesivir was approved by the US Food and Drug Administration as a treatment for COVID-19 after the country reported more than 71,600 new cases on Thursday, nearing record highs set in July, according to Johns Hopkins University data.
NZDUSD – pair broke above the major resistance level at 0.6659 which is additionally strengthened by 50 SMA (green line). As long as the price sits above it, then resistance at 0.6770 may come into play. Source: xStation5This content has been created by XTB S.A. This service is provided by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, entered in the register of entrepreneurs of the National Court Register (Krajowy Rejestr Sądowy) conducted by District Court for the Capital City of Warsaw, XII Commercial Division of the National Court Register under KRS number 0000217580, REGON number 015803782 and Tax Identification Number (NIP) 527-24-43-955, with the fully paid up share capital in the amount of PLN 5.869.181,75. XTB S.A. conducts brokerage activities on the basis of the license granted by Polish Securities and Exchange Commission on 8th November 2005 No. DDM-M-4021-57-1/2005 and is supervised by Polish Supervision Authority.
